BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 36995483)

  • 1. Incidence and risk outcomes of second primary malignancy of patients with post-operative colorectal cancer.
    Yang J; Wu F; An H; Gan H
    Int J Colorectal Dis; 2023 Mar; 38(1):88. PubMed ID: 36995483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Second Primary Malignancies in Patients with Colorectal Cancer: A Population-Based Analysis.
    Jia H; Li Q; Yuan J; Sun X; Wu Z
    Oncologist; 2020 Apr; 25(4):e644-e650. PubMed ID: 31943509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Incidence Characteristics of Second Primary Malignancy after Diagnosis of Primary Colon and Rectal Cancer: A Population Based Study.
    Guan X; Jin Y; Chen Y; Jiang Z; Liu Z; Zhao Z; Yan P; Wang G; Wang X
    PLoS One; 2015; 10(11):e0143067. PubMed ID: 26571301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of age at the time of radiotherapy for localized prostate cancer on the development of second primary malignancies.
    Krasnow RE; Rodríguez D; Nagle RT; Mossanen M; Kibel AS; Chang SL
    Urol Oncol; 2018 Nov; 36(11):500.e11-500.e19. PubMed ID: 30249519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence factors of the survival in colorectal cancer patients with second primary malignancy after surgery: A SEER database analysis.
    Liu L; Chen B
    Medicine (Baltimore); 2023 Oct; 102(40):e35286. PubMed ID: 37800769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between postoperative radiotherapy for young-onset head and neck cancer and long-term risk of second primary malignancy: a population-based study.
    Zhu X; Zhou J; Zhou L; Zhang M; Gao C; Tao L
    J Transl Med; 2022 Sep; 20(1):405. PubMed ID: 36064552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of Second Primary Malignancies Following Colorectal Cancer: A Distinct Pattern of Occurrence Between Colon and Rectal Cancers and Association of Co-Morbidity with Second Primary Malignancies in a Population-Based Cohort of 98,876 Patients in Taiwan.
    Lee YT; Liu CJ; Hu YW; Teng CJ; Tzeng CH; Yeh CM; Chen TJ; Lin JK; Lin CC; Lan YT; Wang HS; Yang SH; Jiang JK; Chen WS; Lin TC; Chang SC; Chen MH; Teng HW; Liu JH; Yen CC
    Medicine (Baltimore); 2015 Jul; 94(26):e1079. PubMed ID: 26131831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Risk of Second Primary Malignancies in Patients With Lung Neuroendocrine Tumors: A Population-Based Study on SEER Database.
    Bu X; Wang X; Wei L; Liu J; Chen M
    Curr Probl Cancer; 2020 Dec; 44(6):100613. PubMed ID: 32563531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Impact of Diabetes Mellitus on the Second Primary Malignancies in Colorectal Cancer Patients.
    Halamkova J; Kazda T; Pehalova L; Gonec R; Kozakova S; Bohovicova L; Slaby O; Demlova R; Svoboda M; Kiss I
    Front Oncol; 2020; 10():573394. PubMed ID: 33585194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The risk of developing second primary malignancies among colorectal cancer patients.
    Du S; Li Y; Sun H; Deng G; Tang S; Zeng F; Zhang B; Cui B
    Aging (Albany NY); 2022 Aug; 14(16):6756-6779. PubMed ID: 36036758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between radiotherapy and risk of second primary malignancies in patients with resectable lung cancer: a population-based study.
    Zhou B; Zang R; Song P; Zhang M; Bie F; Bai G; Li Y; Huai Q; Han Y; Gao S
    J Transl Med; 2023 Jan; 21(1):10. PubMed ID: 36624443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of second primary malignancies in survivors of pancreatic neuroendocrine neoplasms from 2000 to 2018.
    Yang Z; Liu L; Leng K; Shi G
    J Gastroenterol Hepatol; 2023 Sep; 38(9):1474-1484. PubMed ID: 37114675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in the risk and burden of second primary malignancy among survivors of smoking-related cancers in the United States.
    Adjei Boakye E; Buchanan P; Hinyard L; Osazuwa-Peters N; Simpson MC; Schootman M; Piccirillo JF
    Int J Cancer; 2019 Jul; 145(1):143-153. PubMed ID: 30613963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignancies diagnosed before and after anal squamous cell carcinomas: A SEER registry analysis.
    Jani KS; Lu SE; Murphy JD; Romesser PB; Jethwa KR; Li D; Chundury A; Wu AJ; Hathout L; Hallemeier CL; Jabbour SK
    Cancer Med; 2021 Jun; 10(11):3575-3583. PubMed ID: 33960690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of second primary malignancies associated with radiotherapy in prostate cancer patients: competing risk analysis.
    Wu Y; Li Y; Han C; Chong Y; Kang K; Liu Z; Zhang F
    Future Oncol; 2022 Feb; 18(4):445-455. PubMed ID: 35018785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second Primary Malignant Neoplasms and Survival in Adolescent and Young Adult Cancer Survivors.
    Keegan THM; Bleyer A; Rosenberg AS; Li Q; Goldfarb M
    JAMA Oncol; 2017 Nov; 3(11):1554-1557. PubMed ID: 28426850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and mortality of second primary malignancies after lymphoma: a population-based analysis.
    Liu Y; Chu Y; Liu J; Ge X; Ding M; Li P; Liu F; Zhou X; Wang X
    Ann Med; 2023; 55(2):2282652. PubMed ID: 38010751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second cancer incidence, risk factor, and specific mortality in head and neck squamous cell carcinoma.
    Lee DH; Roh JL; Baek S; Jung JH; Choi SH; Nam SY; Kim SY
    Otolaryngol Head Neck Surg; 2013 Oct; 149(4):579-86. PubMed ID: 23820107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality patterns of patients with tonsillar squamous cell carcinoma: a population-based study.
    Wang J; Li X; Niu D; Huang J; Ye E; Zhao Y; Yue S; Hou X; Wu J
    Front Endocrinol (Lausanne); 2023; 14():1158593. PubMed ID: 38130394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of Second Primary Malignancies in Patients With Follicular Lymphoma: A United States Population-based Study.
    Giri S; Bhatt VR; Verma V; Pathak R; Bociek RG; Vose JM; Armitage JO
    Clin Lymphoma Myeloma Leuk; 2017 Sep; 17(9):569-574. PubMed ID: 28709798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.